Antiepileptic drugs and suicidality: An expert consensus statement from the Task Force on Therapeutic Strategies of the ILAE Commission on Neuropsychobiology
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Summary: In 2008, the U.S. Food and Drug Administration (FDA) issued an alert to health care professionals about an increased risk of suicide ideation and suicide behavior in people treated with antiepileptic drugs (AEDs). Since then, a number of retrospective cohort and case–control studies have been published that are trying to address this issue, but gathered results are contradictory. This report represents an expert consensus statement developed by an ad hoc task force of the Commission on Neuropsychobiology of the International League Against Epilepsy (ILAE). Although some (but not all) AEDs can be associated with treatment‐emergent psychiatric problems that can lead to suicidal ideation and behavior, the actual suicidal risk is yet to be established, but it seems to be very low. The risk of stopping AEDs or refusing to start AEDs is significantly worse and can actually result in serious harm including death to the patient. Suicidality in epilepsy is multifactorial, and different variables are operant. Clinicians should investigate the existence of such risk factors and adopt appropriate screening instruments. If necessary, patients should be referred for a psychiatric evaluation, but AED treatment should not be withheld, even in patients with positive suicidal risks. When starting an AED or switching from one to other AEDs, patients should be advised to report to their treating physician any change in mood and suicidal ideation. Data on treatment‐emergent psychiatric adverse events need to be collected, in addition to general safety information, during controlled studies in order to have meaningful information for patients and their relatives when a new drug is marketed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Posner, K., Brown, G. K., Stanley, B., Brent, D. A., Yershova, K. V., Oquendo, M. A., Currier, G. W., Melvin, G. A., Greenhill, L., Shen, S., et al. (2011) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2011.10111704 · Cited by 5,157 · cited 1×
“The Columbia Suicide Severity Rating Scale (C-SSRS) represents a suitable and reliable instrument to evaluate suicidality (Posner et al., 2011) and it is available in several languages (Korean, Japanese, Chinese, Afrikaans, French, Bulgarian, Czech, Dutch for Belgium, Dutch for The Netherlands, English, English for So…”
Suicide as an outcome for mental disorders: A meta-analysis
Harris, E. C., & Barraclough, B. (1997) · British Journal of Psychiatry · doi:10.1192/bjp.170.3.205 · Cited by 2,589
Fatal and non-fatal repetition of self-harm: Systematic review
Owens, D., Horrocks, J., & House, A. (2002) · British Journal of Psychiatry · doi:10.1192/bjp.181.3.193 · Cited by 1,241
Depression and suicide attempt as risk factors for incident unprovoked seizures
Hesdorffer, D. C., Hauser, W. A., Olafsson, E., Ludvigsson, P., & Kjartansson, O. (2006) · Annals of Neurology · doi:10.1002/ana.20685 · Cited by 524
Suicide-Related Events in Patients Treated with Antiepileptic Drugs
Arana, A., Wentworth, C. E., Ayuso-Mateos, J. L., & Arellano, F. M. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0909801 · Cited by 205
Relationship Between Antiepileptic Drugs and Suicide Attempts in Patients With Bipolar Disorder
Gibbons, R. D., Hur, K., Brown, C. H., & Mann, J. J. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2009.159 · Cited by 156 · cited 1×
“The majority of studies included data from patients with epilepsy, whereas some authors focused on psychiatric subjects only (Gibbons et al., 2009).”
Background
Cited by
New avenues for anti-epileptic drug discovery and development
Löscher, W., Klitgaard, H., Twyman, R. E., & Schmidt, D. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4126 · Cited by 675
How addictive are gabapentin and pregabalin? A systematic review
Bonnet, U., & Scherbaum, N. (2017) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2017.08.430 · Cited by 281
Psychiatric Comorbidities in People With Epilepsy
Mula, M., Kanner, A. M., Jetté, N., & Sander, J. W. (2021) · Neurology Clinical Practice · doi:10.1212/cpj.0000000000000874 · Cited by 256
Self-citationBaandrup, L. (2020) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.13384 · Cited by 79
Suicidal Behavior in Mood Disorders: Response to Pharmacological Treatment
Tondo, L., & Baldessarini, R. J. (2016) · Current Psychiatry Reports · doi:10.1007/s11920-016-0715-0 · Cited by 71
Metadata
- Authors
- Mula, M., Kanner, A. M., Schmitz, B., & Schachter, S.
- Venue
- Epilepsia
- Publisher
- Wiley
- Published
- 2012-09-20
- Volume
- 54
- Issue
- 1
- Pages
- 199-203
- ISSN
- 0013-9580 (ISSN-L)
- 1528-1167
- OpenAlex
- W1622861445
- Cited by
- 144
- References
- 6
- FWCI
- 7.79
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Antiepileptic drugs and suicidality: An expert consensus statement from the Task Force on Therapeutic Strategies of the ILAE Commission on Neuropsychobiology. https://app.cochat.ai/papers/10.1111/j.1528-1167.2012.03688.x
- The paper
- Mula, M., Kanner, A. M., Schmitz, B., & Schachter, S. (2013). Antiepileptic drugs and suicidality: An expert consensus statement from the Task Force on Therapeutic Strategies of the ILAE Commission on Neuropsychobiology. Epilepsia. https://doi.org/10.1111/j.1528-1167.2012.03688.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.